nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—atherosclerosis	0.217	1	CbGaD
Dronedarone—ALB—Rosuvastatin—atherosclerosis	0.072	0.157	CbGbCtD
Dronedarone—CYP2D6—Niacin—atherosclerosis	0.0417	0.0908	CbGbCtD
Dronedarone—ABCB1—Ezetimibe—atherosclerosis	0.0377	0.0819	CbGbCtD
Dronedarone—ABCB1—Simvastatin—atherosclerosis	0.035	0.0762	CbGbCtD
Dronedarone—ABCB1—Pravastatin—atherosclerosis	0.0343	0.0745	CbGbCtD
Dronedarone—ABCB1—Lovastatin—atherosclerosis	0.0343	0.0745	CbGbCtD
Dronedarone—CYP2D6—Simvastatin—atherosclerosis	0.033	0.0718	CbGbCtD
Dronedarone—CYP2D6—Lovastatin—atherosclerosis	0.0323	0.0702	CbGbCtD
Dronedarone—CYP2D6—Pravastatin—atherosclerosis	0.0323	0.0702	CbGbCtD
Dronedarone—CYP3A4—Ezetimibe—atherosclerosis	0.0226	0.0491	CbGbCtD
Dronedarone—CYP3A4—Rosuvastatin—atherosclerosis	0.0226	0.0491	CbGbCtD
Dronedarone—CYP3A4—Simvastatin—atherosclerosis	0.021	0.0456	CbGbCtD
Dronedarone—CYP3A4—Lovastatin—atherosclerosis	0.0205	0.0447	CbGbCtD
Dronedarone—CYP3A4—Pravastatin—atherosclerosis	0.0205	0.0447	CbGbCtD
Dronedarone—HCN4—cardiovascular system—atherosclerosis	0.00443	0.115	CbGeAlD
Dronedarone—Interstitial lung disease—Ezetimibe—atherosclerosis	0.0042	0.0351	CcSEcCtD
Dronedarone—Interstitial lung disease—Simvastatin—atherosclerosis	0.004	0.0335	CcSEcCtD
Dronedarone—Interstitial lung disease—Pravastatin—atherosclerosis	0.00362	0.0303	CcSEcCtD
Dronedarone—HCN2—cardiovascular system—atherosclerosis	0.00336	0.087	CbGeAlD
Dronedarone—HCN3—adipose tissue—atherosclerosis	0.00316	0.0819	CbGeAlD
Dronedarone—Vasculitis—Lovastatin—atherosclerosis	0.0031	0.026	CcSEcCtD
Dronedarone—Vasculitis—Ezetimibe—atherosclerosis	0.00304	0.0255	CcSEcCtD
Dronedarone—HCN2—adipose tissue—atherosclerosis	0.00296	0.0767	CbGeAlD
Dronedarone—Vasculitis—Simvastatin—atherosclerosis	0.0029	0.0243	CcSEcCtD
Dronedarone—Vasculitis—Pravastatin—atherosclerosis	0.00262	0.0219	CcSEcCtD
Dronedarone—Eczema—Simvastatin—atherosclerosis	0.00229	0.0191	CcSEcCtD
Dronedarone—HCN3—liver—atherosclerosis	0.00222	0.0574	CbGeAlD
Dronedarone—Eczema—Niacin—atherosclerosis	0.0021	0.0176	CcSEcCtD
Dronedarone—CACNA1S—cardiovascular system—atherosclerosis	0.00189	0.049	CbGeAlD
Dronedarone—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00189	0.0158	CcSEcCtD
Dronedarone—CACNB1—cardiovascular system—atherosclerosis	0.00176	0.0457	CbGeAlD
Dronedarone—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00173	0.0145	CcSEcCtD
Dronedarone—KCNK2—adipose tissue—atherosclerosis	0.00173	0.0448	CbGeAlD
Dronedarone—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.0017	0.0142	CcSEcCtD
Dronedarone—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00162	0.0136	CcSEcCtD
Dronedarone—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00157	0.0131	CcSEcCtD
Dronedarone—CACNB1—adipose tissue—atherosclerosis	0.00155	0.0403	CbGeAlD
Dronedarone—CACNB3—adipose tissue—atherosclerosis	0.00149	0.0387	CbGeAlD
Dronedarone—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00147	0.0123	CcSEcCtD
Dronedarone—Angioedema—Rosuvastatin—atherosclerosis	0.00143	0.0119	CcSEcCtD
Dronedarone—Angiopathy—Ezetimibe—atherosclerosis	0.00135	0.0113	CcSEcCtD
Dronedarone—Immune system disorder—Ezetimibe—atherosclerosis	0.00135	0.0113	CcSEcCtD
Dronedarone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00134	0.0112	CcSEcCtD
Dronedarone—Erythema—Ezetimibe—atherosclerosis	0.0013	0.0109	CcSEcCtD
Dronedarone—Dysgeusia—Lovastatin—atherosclerosis	0.0013	0.0108	CcSEcCtD
Dronedarone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00125	0.0105	CcSEcCtD
Dronedarone—Erythema—Simvastatin—atherosclerosis	0.00124	0.0104	CcSEcCtD
Dronedarone—Dysgeusia—Simvastatin—atherosclerosis	0.00121	0.0101	CcSEcCtD
Dronedarone—Angioedema—Lovastatin—atherosclerosis	0.00121	0.0101	CcSEcCtD
Dronedarone—Cardiac disorder—Pravastatin—atherosclerosis	0.00119	0.00998	CcSEcCtD
Dronedarone—Angioedema—Ezetimibe—atherosclerosis	0.00119	0.00992	CcSEcCtD
Dronedarone—Angiopathy—Niacin—atherosclerosis	0.00118	0.00991	CcSEcCtD
Dronedarone—Erythema—Niacin—atherosclerosis	0.00114	0.00951	CcSEcCtD
Dronedarone—CACNB2—cardiovascular system—atherosclerosis	0.00114	0.0295	CbGeAlD
Dronedarone—Angioedema—Simvastatin—atherosclerosis	0.00113	0.00946	CcSEcCtD
Dronedarone—Dyspepsia—Rosuvastatin—atherosclerosis	0.00112	0.00939	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0011	0.00918	CcSEcCtD
Dronedarone—Dysgeusia—Pravastatin—atherosclerosis	0.0011	0.00917	CcSEcCtD
Dronedarone—Anaphylactic shock—Lovastatin—atherosclerosis	0.00108	0.00904	CcSEcCtD
Dronedarone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00106	0.00886	CcSEcCtD
Dronedarone—CACNA1C—connective tissue—atherosclerosis	0.00105	0.0273	CbGeAlD
Dronedarone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00104	0.00872	CcSEcCtD
Dronedarone—Nervous system disorder—Ezetimibe—atherosclerosis	0.00104	0.00869	CcSEcCtD
Dronedarone—Angioedema—Niacin—atherosclerosis	0.00104	0.00869	CcSEcCtD
Dronedarone—Skin disorder—Ezetimibe—atherosclerosis	0.00103	0.00861	CcSEcCtD
Dronedarone—Angioedema—Pravastatin—atherosclerosis	0.00102	0.00856	CcSEcCtD
Dronedarone—Anaphylactic shock—Simvastatin—atherosclerosis	0.00101	0.00845	CcSEcCtD
Dronedarone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00101	0.00843	CcSEcCtD
Dronedarone—CACNA1D—cardiovascular system—atherosclerosis	0.000993	0.0258	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000961	0.00804	CcSEcCtD
Dronedarone—Dyspepsia—Lovastatin—atherosclerosis	0.000951	0.00795	CcSEcCtD
Dronedarone—Dyspepsia—Ezetimibe—atherosclerosis	0.000933	0.0078	CcSEcCtD
Dronedarone—Fatigue—Lovastatin—atherosclerosis	0.000931	0.00779	CcSEcCtD
Dronedarone—Anaphylactic shock—Niacin—atherosclerosis	0.000928	0.00776	CcSEcCtD
Dronedarone—CACNA1C—cardiovascular system—atherosclerosis	0.000917	0.0238	CbGeAlD
Dronedarone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000915	0.00765	CcSEcCtD
Dronedarone—Asthenia—Rosuvastatin—atherosclerosis	0.000915	0.00765	CcSEcCtD
Dronedarone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000914	0.00764	CcSEcCtD
Dronedarone—Fatigue—Ezetimibe—atherosclerosis	0.000914	0.00764	CcSEcCtD
Dronedarone—Pruritus—Rosuvastatin—atherosclerosis	0.000902	0.00754	CcSEcCtD
Dronedarone—Skin disorder—Niacin—atherosclerosis	0.000901	0.00754	CcSEcCtD
Dronedarone—Dyspepsia—Simvastatin—atherosclerosis	0.000889	0.00744	CcSEcCtD
Dronedarone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000883	0.00739	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000872	0.0073	CcSEcCtD
Dronedarone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000872	0.0073	CcSEcCtD
Dronedarone—Fatigue—Simvastatin—atherosclerosis	0.000871	0.00729	CcSEcCtD
Dronedarone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000866	0.00725	CcSEcCtD
Dronedarone—Abdominal pain—Lovastatin—atherosclerosis	0.000854	0.00714	CcSEcCtD
Dronedarone—Abdominal pain—Ezetimibe—atherosclerosis	0.000838	0.00701	CcSEcCtD
Dronedarone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000826	0.00691	CcSEcCtD
Dronedarone—ADRB1—connective tissue—atherosclerosis	0.000822	0.0213	CbGeAlD
Dronedarone—Dyspepsia—Niacin—atherosclerosis	0.000817	0.00683	CcSEcCtD
Dronedarone—CACNA1C—adipose tissue—atherosclerosis	0.000808	0.021	CbGeAlD
Dronedarone—Dyspepsia—Pravastatin—atherosclerosis	0.000804	0.00673	CcSEcCtD
Dronedarone—Rash—Rosuvastatin—atherosclerosis	0.000804	0.00672	CcSEcCtD
Dronedarone—Dermatitis—Rosuvastatin—atherosclerosis	0.000803	0.00672	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000801	0.0067	CcSEcCtD
Dronedarone—Abdominal pain—Simvastatin—atherosclerosis	0.000799	0.00668	CcSEcCtD
Dronedarone—Fatigue—Pravastatin—atherosclerosis	0.000788	0.00659	CcSEcCtD
Dronedarone—Asthenia—Lovastatin—atherosclerosis	0.000775	0.00648	CcSEcCtD
Dronedarone—Pruritus—Lovastatin—atherosclerosis	0.000764	0.00639	CcSEcCtD
Dronedarone—Asthenia—Ezetimibe—atherosclerosis	0.00076	0.00636	CcSEcCtD
Dronedarone—Gastrointestinal pain—Niacin—atherosclerosis	0.000759	0.00635	CcSEcCtD
Dronedarone—Nausea—Rosuvastatin—atherosclerosis	0.000757	0.00633	CcSEcCtD
Dronedarone—Pruritus—Ezetimibe—atherosclerosis	0.00075	0.00627	CcSEcCtD
Dronedarone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000747	0.00625	CcSEcCtD
Dronedarone—Diarrhoea—Lovastatin—atherosclerosis	0.000739	0.00618	CcSEcCtD
Dronedarone—Abdominal pain—Niacin—atherosclerosis	0.000733	0.00614	CcSEcCtD
Dronedarone—Asthenia—Simvastatin—atherosclerosis	0.000725	0.00606	CcSEcCtD
Dronedarone—Diarrhoea—Ezetimibe—atherosclerosis	0.000725	0.00606	CcSEcCtD
Dronedarone—Abdominal pain—Pravastatin—atherosclerosis	0.000722	0.00604	CcSEcCtD
Dronedarone—ADRB1—cardiovascular system—atherosclerosis	0.000715	0.0185	CbGeAlD
Dronedarone—Pruritus—Simvastatin—atherosclerosis	0.000715	0.00598	CcSEcCtD
Dronedarone—CACNB2—liver—atherosclerosis	0.000703	0.0182	CbGeAlD
Dronedarone—Diarrhoea—Simvastatin—atherosclerosis	0.000691	0.00578	CcSEcCtD
Dronedarone—Vomiting—Lovastatin—atherosclerosis	0.000687	0.00575	CcSEcCtD
Dronedarone—Rash—Lovastatin—atherosclerosis	0.000681	0.0057	CcSEcCtD
Dronedarone—Dermatitis—Lovastatin—atherosclerosis	0.000681	0.00569	CcSEcCtD
Dronedarone—Vomiting—Ezetimibe—atherosclerosis	0.000674	0.00564	CcSEcCtD
Dronedarone—Rash—Ezetimibe—atherosclerosis	0.000668	0.00559	CcSEcCtD
Dronedarone—Dermatitis—Ezetimibe—atherosclerosis	0.000667	0.00558	CcSEcCtD
Dronedarone—Asthenia—Niacin—atherosclerosis	0.000666	0.00557	CcSEcCtD
Dronedarone—Pruritus—Niacin—atherosclerosis	0.000656	0.00549	CcSEcCtD
Dronedarone—Asthenia—Pravastatin—atherosclerosis	0.000655	0.00548	CcSEcCtD
Dronedarone—Pruritus—Pravastatin—atherosclerosis	0.000646	0.00541	CcSEcCtD
Dronedarone—Vomiting—Simvastatin—atherosclerosis	0.000642	0.00537	CcSEcCtD
Dronedarone—Nausea—Lovastatin—atherosclerosis	0.000642	0.00537	CcSEcCtD
Dronedarone—Rash—Simvastatin—atherosclerosis	0.000637	0.00533	CcSEcCtD
Dronedarone—Dermatitis—Simvastatin—atherosclerosis	0.000637	0.00532	CcSEcCtD
Dronedarone—Diarrhoea—Niacin—atherosclerosis	0.000635	0.00531	CcSEcCtD
Dronedarone—ADRB1—adipose tissue—atherosclerosis	0.000631	0.0164	CbGeAlD
Dronedarone—Nausea—Ezetimibe—atherosclerosis	0.000629	0.00526	CcSEcCtD
Dronedarone—Diarrhoea—Pravastatin—atherosclerosis	0.000625	0.00523	CcSEcCtD
Dronedarone—CACNA1D—liver—atherosclerosis	0.000614	0.0159	CbGeAlD
Dronedarone—Nausea—Simvastatin—atherosclerosis	0.0006	0.00502	CcSEcCtD
Dronedarone—Vomiting—Niacin—atherosclerosis	0.00059	0.00493	CcSEcCtD
Dronedarone—Rash—Niacin—atherosclerosis	0.000585	0.00489	CcSEcCtD
Dronedarone—Dermatitis—Niacin—atherosclerosis	0.000584	0.00489	CcSEcCtD
Dronedarone—Vomiting—Pravastatin—atherosclerosis	0.000581	0.00486	CcSEcCtD
Dronedarone—Rash—Pravastatin—atherosclerosis	0.000576	0.00482	CcSEcCtD
Dronedarone—Dermatitis—Pravastatin—atherosclerosis	0.000575	0.00481	CcSEcCtD
Dronedarone—ADRA1A—cardiovascular system—atherosclerosis	0.000566	0.0147	CbGeAlD
Dronedarone—Nausea—Niacin—atherosclerosis	0.000551	0.00461	CcSEcCtD
Dronedarone—KCNH2—cardiovascular system—atherosclerosis	0.000546	0.0142	CbGeAlD
Dronedarone—Nausea—Pravastatin—atherosclerosis	0.000543	0.00454	CcSEcCtD
Dronedarone—ABCB1—blood vessel—atherosclerosis	0.000537	0.0139	CbGeAlD
Dronedarone—ADRA1A—adipose tissue—atherosclerosis	0.000499	0.0129	CbGeAlD
Dronedarone—ADRA2A—connective tissue—atherosclerosis	0.000494	0.0128	CbGeAlD
Dronedarone—ADRA2C—adipose tissue—atherosclerosis	0.000475	0.0123	CbGeAlD
Dronedarone—ALB—liver—atherosclerosis	0.00044	0.0114	CbGeAlD
Dronedarone—ADRA2A—adipose tissue—atherosclerosis	0.000379	0.00983	CbGeAlD
Dronedarone—ADRA1A—liver—atherosclerosis	0.00035	0.00907	CbGeAlD
Dronedarone—ADRA2C—liver—atherosclerosis	0.000333	0.00864	CbGeAlD
Dronedarone—ABCB1—cardiovascular system—atherosclerosis	0.00024	0.00621	CbGeAlD
Dronedarone—ABCB1—adipose tissue—atherosclerosis	0.000211	0.00548	CbGeAlD
Dronedarone—CYP3A4—liver—atherosclerosis	0.000209	0.00543	CbGeAlD
Dronedarone—CYP2D6—liver—atherosclerosis	0.000206	0.00534	CbGeAlD
Dronedarone—ABCB1—liver—atherosclerosis	0.000148	0.00384	CbGeAlD
Dronedarone—ADRA2C—Metabolism—ALB—atherosclerosis	8.19e-06	4.97e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	8.17e-06	4.96e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GSTM1—atherosclerosis	8.15e-06	4.95e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	8.14e-06	4.94e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—F2—atherosclerosis	8.12e-06	4.93e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	8.09e-06	4.91e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—INS—atherosclerosis	8.07e-06	4.9e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	8.03e-06	4.87e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—LPL—atherosclerosis	8e-06	4.86e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—INS—atherosclerosis	8e-06	4.85e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	7.99e-06	4.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	7.99e-06	4.85e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCL2—atherosclerosis	7.94e-06	4.82e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.94e-06	4.82e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	7.89e-06	4.79e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	7.87e-06	4.78e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—NOS3—atherosclerosis	7.84e-06	4.76e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IGF1—atherosclerosis	7.81e-06	4.74e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—GPX1—atherosclerosis	7.8e-06	4.74e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AGT—atherosclerosis	7.8e-06	4.74e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	7.77e-06	4.72e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	7.77e-06	4.71e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	7.74e-06	4.7e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PIK3CG—atherosclerosis	7.67e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—HMOX1—atherosclerosis	7.66e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—LEP—atherosclerosis	7.65e-06	4.64e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—APOE—atherosclerosis	7.65e-06	4.64e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CD36—atherosclerosis	7.6e-06	4.61e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	7.58e-06	4.6e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	7.56e-06	4.59e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	7.56e-06	4.59e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—INS—atherosclerosis	7.47e-06	4.53e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	7.44e-06	4.52e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	7.43e-06	4.51e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	7.42e-06	4.5e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PPARG—atherosclerosis	7.4e-06	4.49e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—INS—atherosclerosis	7.35e-06	4.46e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	7.35e-06	4.46e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	7.35e-06	4.46e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOB—atherosclerosis	7.34e-06	4.46e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	7.3e-06	4.43e-05	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—AKT1—atherosclerosis	7.28e-06	4.42e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—INS—atherosclerosis	7.26e-06	4.41e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AGT—atherosclerosis	7.25e-06	4.4e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	7.24e-06	4.39e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	7.23e-06	4.39e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.22e-06	4.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—AKT1—atherosclerosis	7.22e-06	4.38e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—F2—atherosclerosis	7.21e-06	4.38e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—MTHFR—atherosclerosis	7.2e-06	4.37e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—atherosclerosis	7.17e-06	4.35e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GSTM1—atherosclerosis	7.14e-06	4.33e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.12e-06	4.32e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	7.11e-06	4.32e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—LEP—atherosclerosis	7.1e-06	4.31e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOE—atherosclerosis	7.1e-06	4.31e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NOS3—atherosclerosis	7.08e-06	4.3e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LIPC—atherosclerosis	7.08e-06	4.29e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARA—atherosclerosis	7.07e-06	4.29e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	7.04e-06	4.27e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOC3—atherosclerosis	7.03e-06	4.27e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	7.02e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	7.01e-06	4.26e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—LPL—atherosclerosis	7.01e-06	4.25e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LDLR—atherosclerosis	6.99e-06	4.24e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOB—atherosclerosis	6.92e-06	4.2e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	6.9e-06	4.19e-05	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—AKT1—atherosclerosis	6.89e-06	4.18e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	6.89e-06	4.18e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	6.86e-06	4.17e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AGT—atherosclerosis	6.84e-06	4.15e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—GPX1—atherosclerosis	6.84e-06	4.15e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CETP—atherosclerosis	6.83e-06	4.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	6.78e-06	4.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	6.75e-06	4.1e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.73e-06	4.08e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOE—atherosclerosis	6.71e-06	4.07e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—F2—atherosclerosis	6.7e-06	4.07e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CD36—atherosclerosis	6.66e-06	4.04e-05	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	6.66e-06	4.04e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ALB—atherosclerosis	6.65e-06	4.04e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CAV1—atherosclerosis	6.64e-06	4.03e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOA1—atherosclerosis	6.63e-06	4.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	6.61e-06	4.01e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—LPL—atherosclerosis	6.6e-06	4.01e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	6.55e-06	3.98e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	6.55e-06	3.98e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.54e-06	3.97e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—INS—atherosclerosis	6.53e-06	3.96e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	6.45e-06	3.91e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—GPX1—atherosclerosis	6.44e-06	3.91e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	6.43e-06	3.9e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	6.41e-06	3.89e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—NOS3—atherosclerosis	6.37e-06	3.86e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	6.32e-06	3.83e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—MTHFR—atherosclerosis	6.31e-06	3.83e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	6.28e-06	3.81e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CD36—atherosclerosis	6.28e-06	3.81e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	6.23e-06	3.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	6.22e-06	3.78e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARA—atherosclerosis	6.19e-06	3.76e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.17e-06	3.75e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	6.17e-06	3.74e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	6.14e-06	3.73e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—INS—atherosclerosis	6.07e-06	3.68e-05	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	6.07e-06	3.68e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	6.06e-06	3.68e-05	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—AKT1—atherosclerosis	6.06e-06	3.68e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PIK3CG—atherosclerosis	6.05e-06	3.67e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	6.05e-06	3.67e-05	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	6.01e-06	3.65e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	6e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AGT—atherosclerosis	6e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—atherosclerosis	5.97e-06	3.62e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	5.97e-06	3.62e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.95e-06	3.61e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	5.92e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOE—atherosclerosis	5.88e-06	3.57e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	5.87e-06	3.56e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PPARG—atherosclerosis	5.84e-06	3.54e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARA—atherosclerosis	5.83e-06	3.54e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—atherosclerosis	5.82e-06	3.53e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CAV1—atherosclerosis	5.82e-06	3.53e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	5.81e-06	3.53e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOA1—atherosclerosis	5.81e-06	3.52e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—INS—atherosclerosis	5.73e-06	3.48e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	5.73e-06	3.48e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	5.72e-06	3.47e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—AKT1—atherosclerosis	5.7e-06	3.46e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—atherosclerosis	5.68e-06	3.45e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AGT—atherosclerosis	5.65e-06	3.43e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	5.63e-06	3.42e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	5.62e-06	3.41e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	5.61e-06	3.41e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	5.6e-06	3.4e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	5.57e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	5.57e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	5.54e-06	3.36e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOE—atherosclerosis	5.54e-06	3.36e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	5.53e-06	3.35e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	5.53e-06	3.35e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	5.52e-06	3.35e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	5.51e-06	3.34e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.5e-06	3.34e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CAV1—atherosclerosis	5.49e-06	3.33e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	5.47e-06	3.32e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOA1—atherosclerosis	5.47e-06	3.32e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	5.46e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	5.44e-06	3.3e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	5.32e-06	3.23e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.3e-06	3.22e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	5.3e-06	3.21e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	5.26e-06	3.19e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	5.2e-06	3.16e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	5.17e-06	3.14e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	5.14e-06	3.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	5.12e-06	3.11e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PPARG—atherosclerosis	5.12e-06	3.11e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	5.11e-06	3.1e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	5.1e-06	3.1e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	5.1e-06	3.09e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	5.08e-06	3.08e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	5.05e-06	3.07e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—atherosclerosis	5.05e-06	3.07e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	5.03e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—NOS3—atherosclerosis	5.02e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—INS—atherosclerosis	5.02e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	5.02e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	5e-06	3.04e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5e-06	3.03e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	4.91e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	4.83e-06	2.93e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	4.82e-06	2.93e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PPARG—atherosclerosis	4.82e-06	2.93e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	4.78e-06	2.9e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—INS—atherosclerosis	4.73e-06	2.87e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.72e-06	2.87e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	4.72e-06	2.87e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	4.72e-06	2.87e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	4.68e-06	2.84e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	4.67e-06	2.84e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	4.65e-06	2.82e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	4.64e-06	2.82e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—atherosclerosis	4.6e-06	2.79e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	4.6e-06	2.79e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	4.6e-06	2.79e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—atherosclerosis	4.59e-06	2.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	4.56e-06	2.77e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	4.55e-06	2.76e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOB—atherosclerosis	4.52e-06	2.74e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	4.49e-06	2.72e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	4.47e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	4.47e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	4.46e-06	2.71e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—NOS3—atherosclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	4.4e-06	2.67e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—atherosclerosis	4.34e-06	2.63e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	4.33e-06	2.63e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—LPL—atherosclerosis	4.32e-06	2.62e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	4.27e-06	2.59e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	4.26e-06	2.59e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	4.22e-06	2.56e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPX1—atherosclerosis	4.21e-06	2.56e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	4.15e-06	2.52e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—NOS3—atherosclerosis	4.15e-06	2.52e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	4.14e-06	2.51e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	4.13e-06	2.5e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CD36—atherosclerosis	4.1e-06	2.49e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	4.09e-06	2.48e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—atherosclerosis	4.03e-06	2.44e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	3.9e-06	2.37e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.89e-06	2.36e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—atherosclerosis	3.87e-06	2.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	3.83e-06	2.33e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARA—atherosclerosis	3.81e-06	2.32e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	3.8e-06	2.3e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.79e-06	2.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	3.79e-06	2.3e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AGT—atherosclerosis	3.69e-06	2.24e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	3.63e-06	2.2e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOE—atherosclerosis	3.62e-06	2.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—AKT1—atherosclerosis	3.6e-06	2.19e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CAV1—atherosclerosis	3.59e-06	2.18e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOA1—atherosclerosis	3.58e-06	2.17e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	3.57e-06	2.17e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—atherosclerosis	3.53e-06	2.14e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	3.52e-06	2.14e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—atherosclerosis	3.5e-06	2.12e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.27e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—atherosclerosis	3.26e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—AKT1—atherosclerosis	3.25e-06	1.98e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	3.22e-06	1.96e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—atherosclerosis	3.21e-06	1.95e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.15e-06	1.91e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—INS—atherosclerosis	3.09e-06	1.88e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	3.01e-06	1.83e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	2.96e-06	1.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—AKT1—atherosclerosis	2.93e-06	1.78e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.85e-06	1.73e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—atherosclerosis	2.83e-06	1.72e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—NOS3—atherosclerosis	2.71e-06	1.65e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2.65e-06	1.61e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	2.63e-06	1.6e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.48e-06	1.51e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	2.45e-06	1.48e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AKT1—atherosclerosis	2.31e-06	1.4e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AKT1—atherosclerosis	2.02e-06	1.23e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AKT1—atherosclerosis	1.91e-06	1.16e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.25e-06	7.57e-06	CbGpPWpGaD
